Beyond the simple isolation of TILs from tumor samples, a technique to improve the specific recognition of T cells has further developed, through the genetic engineering of T cell receptor (TCR), which is highly specific for the recognition of MHC-restricted peptides [59]. Here, HLA-C is linked to neoplasm.